You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Early diagnostic value of survivin and its alternative splice variants in breast cancer
|
|---|---|
| Published in |
BMC Cancer, March 2014
|
| DOI | 10.1186/1471-2407-14-176 |
| Pubmed ID | |
| Authors |
Salma Khan, Heather Ferguson Bennit, David Turay, Mia Perez, Saied Mirshahidi, Yuan Yuan, Nathan R Wall |
| Abstract |
The inhibitor of apoptosis (IAP) protein Survivin and its splice variants are differentially expressed in breast cancer tissues. Our previous work showed Survivin is released from tumor cells via small membrane-bound vesicles called exosomes. We, therefore, hypothesize that analysis of serum exosomal Survivin and its splice variants may provide a novel biomarker for early diagnosis of breast cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | <1% |
| Ireland | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 183 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 49 | 26% |
| Researcher | 26 | 14% |
| Student > Bachelor | 17 | 9% |
| Student > Master | 16 | 9% |
| Other | 12 | 6% |
| Other | 28 | 15% |
| Unknown | 38 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 44 | 24% |
| Medicine and Dentistry | 34 | 18% |
| Agricultural and Biological Sciences | 28 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Engineering | 7 | 4% |
| Other | 19 | 10% |
| Unknown | 46 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#3,501,834
of 23,880,375 outputs
Outputs from BMC Cancer
#838
of 8,505 outputs
Outputs of similar age
#34,835
of 224,521 outputs
Outputs of similar age from BMC Cancer
#20
of 133 outputs
Altmetric has tracked 23,880,375 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,505 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,521 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.